Home Combat Arthritis Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Nov 21, 2020 comments off

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.

Read More…

You May Also Like

U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie – Reuters

Antibody levels higher after Moderna shot; Lilly arthritis drug used with steroid cuts death risk – Reuters

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients – Reuters India

Podiatrists debunk 12 feet myths

NIH starts study of COVID-19 booster shot in people with autoimmune diseases – Reuters

Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data